Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Zoulim

Showing results (111-120 of 127) with videos related to

Pageof 13
Sort By:
The Journal of General Virology|July 18, 2008
Initiation of hepatitis B virus genome replication and production of infectious virus following delivery in HepG2 cells by novel recombinant baculovirus vectorJ Lucifora, D Durantel, L Belloni, et al.
Journal of Viral Hepatitis|February 7, 2013
New HBV subgenotype D9, a novel D/C recombinant, identified in patients with chronic HBeAg-negative infection in Eastern IndiaS Ghosh, P Banerjee, P Deny, et al.
Gastroenterologie Clinique Et Biologique|April 12, 2008
Long-term results of liver transplantation for Wilson's diseaseV Pabón, J Dumortier, R Gincul, et al.
Oncogene|August 8, 2017
Reciprocal antagonism between the netrin-1 receptor uncoordinated-phenotype-5A (UNC5A) and the hepatitis C virusM-L Plissonnier, T Lahlali, M Raab, et al.
Journal of Viral Hepatitis|April 17, 2018
Precore G1896A mutation is associated with reduced rates of HBsAg seroclearance in treated HIV hepatitis B virus co-infected patients from Western AfricaA Boyd, R Moh, S Maylin, et al.
Journal of Viral Hepatitis|December 19, 1998
Clinical evaluation of the branched DNA assay for hepatitis B virus DNA detection in patients with chronic hepatitis B lacking hepatitis B e antigen and treated with interferon-alphaF Habersetzer, F Zoulim, J F Jusot, et al.
Antimicrobial Agents and Chemotherapy|December 22, 1999
Characterization of the antiviral effect of 2',3'-dideoxy-2', 3'-didehydro-beta-L-5-fluorocytidine in the duck hepatitis B virus infection modelF Le Guerhier, C Pichoud, S Guerret, et al.
Antimicrobial Agents and Chemotherapy|June 25, 2004
Effect of a combination of clevudine and emtricitabine with adenovirus-mediated delivery of gamma interferon in the woodchuck model of hepatitis B virus infectionA C Jacquard, M Nassal, C Pichoud, et al.
Journal of Viral Hepatitis|June 30, 2016
Implementation of an in-house quantitative real-time polymerase chain reaction method for Hepatitis B virus quantification in West African countriesS Ghosh, A Sow, C Guillot, et al.
Journal of Viral Hepatitis|January 9, 2016
Characterization of hepatitis B virus surface antigen variability and impact on HBs antigen clearance under nucleos(t)ide analogue therapyA Velay, H Jeulin, M Eschlimann, et al.
Pageof 13

Showing results (111-120 of 127) with videos related to

Sort By:
Pageof 13
The Journal of General Virology|July 18, 2008
Initiation of hepatitis B virus genome replication and production of infectious virus following delivery in HepG2 cells by novel recombinant baculovirus vectorJ Lucifora, D Durantel, L Belloni, et al.
Journal of Viral Hepatitis|February 7, 2013
New HBV subgenotype D9, a novel D/C recombinant, identified in patients with chronic HBeAg-negative infection in Eastern IndiaS Ghosh, P Banerjee, P Deny, et al.
Gastroenterologie Clinique Et Biologique|April 12, 2008
Long-term results of liver transplantation for Wilson's diseaseV Pabón, J Dumortier, R Gincul, et al.
Oncogene|August 8, 2017
Reciprocal antagonism between the netrin-1 receptor uncoordinated-phenotype-5A (UNC5A) and the hepatitis C virusM-L Plissonnier, T Lahlali, M Raab, et al.
Journal of Viral Hepatitis|April 17, 2018
Precore G1896A mutation is associated with reduced rates of HBsAg seroclearance in treated HIV hepatitis B virus co-infected patients from Western AfricaA Boyd, R Moh, S Maylin, et al.
Journal of Viral Hepatitis|December 19, 1998
Clinical evaluation of the branched DNA assay for hepatitis B virus DNA detection in patients with chronic hepatitis B lacking hepatitis B e antigen and treated with interferon-alphaF Habersetzer, F Zoulim, J F Jusot, et al.
Antimicrobial Agents and Chemotherapy|December 22, 1999
Characterization of the antiviral effect of 2',3'-dideoxy-2', 3'-didehydro-beta-L-5-fluorocytidine in the duck hepatitis B virus infection modelF Le Guerhier, C Pichoud, S Guerret, et al.
Antimicrobial Agents and Chemotherapy|June 25, 2004
Effect of a combination of clevudine and emtricitabine with adenovirus-mediated delivery of gamma interferon in the woodchuck model of hepatitis B virus infectionA C Jacquard, M Nassal, C Pichoud, et al.
Journal of Viral Hepatitis|June 30, 2016
Implementation of an in-house quantitative real-time polymerase chain reaction method for Hepatitis B virus quantification in West African countriesS Ghosh, A Sow, C Guillot, et al.
Journal of Viral Hepatitis|January 9, 2016
Characterization of hepatitis B virus surface antigen variability and impact on HBs antigen clearance under nucleos(t)ide analogue therapyA Velay, H Jeulin, M Eschlimann, et al.
Pageof 13